Results 81 to 90 of about 7,288 (241)

Social support for the chronically ill during lockdown. Qualitative research in the COVID‐19 pandemic

open access: yesSociology of Health &Illness, Volume 47, Issue 1, January 2025.
Abstract Chronic illness requires a web of actors, both professional and familiar, who constitute the support network of the chronically ill. This article aims to analyse how the COVID‐19 pandemic has impacted on the delicate balance of these supports. Qualitative research was conducted among people with four types of chronic diseases in France: cystic
Louise Virole   +2 more
wiley   +1 more source

Mucoviscidose, spécialisation en médecine et dépistage néonatal systématique (Commentaire) [PDF]

open access: yes, 2004
Frattini Marie-Odile, Naiditch Michel. Mucoviscidose, spécialisation en médecine et dépistage néonatal systématique (Commentaire). In: Sciences sociales et santé. Volume 22, n°4, 2004. pp.
Frattini, Marie-Odile, Naiditch, Michel
core   +1 more source

Mucoviscidose et test à la sueur normal [PDF]

open access: yes, 2001
[Cystic fibrosis and normal sweat chloride values: a case-report] Observation : En présence d'une symptomatologie suggestive, la normalité du test à la sueur ne suffit pas toujours à exclure un diagnostic de mucoviscidose.
Lebecque, Patrick   +2 more
core  

Utility of Pulse Wave Amplitude Drops in Assessing the Severity of Obstructive Sleep Apnea in Children and Adolescents

open access: yes
Pediatric Pulmonology, Volume 60, Issue 7, July 2025.
Iulia Ioan   +6 more
wiley   +1 more source

La mucoviscidose (actualité thérapeutique dans le traitement de la mucoviscidose) [PDF]

open access: yes, 2009
Maladie rare qui a bénéficié au cours des dernières années, d'une modification importante dans l'organisation des soins, d'une amélioration de l'espérance de vie et d'une meilleure compréhension des mécanismes physiopathologiques en cause. L'espérance de
BACHOUEL, Zied, CAVE, Christian
core  

Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa

open access: yesBMC Microbiology, 2019
Background Methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa are becoming difficult to treat with antibiotics whereas Cationic Antimicrobial Peptides (CAMPs) represent promising alternatives.
Regina Geitani   +3 more
doaj   +1 more source

Fibrose Cística: Diagnóstico e Tratamento

open access: yesClinical and Biomedical Research, 2011
Fibrose Cística, também chamada de mucoviscidose, é uma doença crônica, de origem genética, causada por um gene defeituoso herdado do pai e outro da mãe. Não é, portanto, uma doença contagiosa.
Anneliese Hoffmann
doaj  

Aberrant Splicing Is the Pathogenicity Mechanism of the p.Glu314Lys Variant in CYP11A1 Gene

open access: yesFrontiers in Endocrinology, 2018
Context: The cholesterol side chain cleavage enzyme (CYP11A1) catalyzes the conversion of cholesterol to pregnenolone, the first rate-limiting step of steroidogenesis.
Claire Goursaud   +22 more
doaj   +1 more source

Toll Like Receptors 4 and 2 Expression in the Bronchial Mucosa of Patients with Cystic Fibrosis

open access: yesCanadian Respiratory Journal, 2005
BACKGROUND: Cystic fibrosis (CF) is a lung disease characterized by chronic infection with Gram-negative bacteria Pseudomonas aeruginosa and Gram-positive bacteria Staphylococcus aureus.
Hans-Peter Hauber   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy